Lower riskMedical device recall · FDA · Published January 24, 2022
Matrix Clinical Solution At-Home COVID-19 Test: Not Authorized for Home Use
Matrix Medical Network recalls its At-Home COVID-19 Test kits because they are not approved for home sample collection. Consumers should check product details and contact the company for guidance.
“Matrix Clinical Solution At-Home COVID-19 Test: Not Authorized for Home Use.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/61226-matrix-clinical-solution-at-home-covid-19-test-not-authorized. Based on FDA recall #Z-0947-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0947-2022%22&limit=1).
The FDA announced on Jan. 24, 2022, that Matrix Medical Network voluntarily recalled its Matrix Clinical Solution At-Home COVID-19 Test because it was not authorized for home sample collection. The recall affects 3,226 kits distributed in 24 states and the District of Columbia.
How to tell if you have it
Brand: Matrix Medical Network
Product: Matrix Clinical Solution At-Home COVID-19 Test
SKU: 15206
Quantity: 3,226 kits
Lot codes: None
The hazard
According to the FDA, the hazard is that the Matrix Clinical Solution At-Home COVID-19 Test was not authorized for home sample collection.
Context
GovInfoNow's records show other recent recalls of similar products include Wondfo Streptococcal A Test (2025-12-19) and GET TESTED Mycotoxin Panel Test Recall (2025-11-03).
How to tell if you have this one
Check for product number SKU: 15206. These kits were sold without lot numbers and are not authorized for home use.
Brand
Matrix Medical Network
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for product number SKU: 15206 on the test kit packaging.
Where it went and when
Where it was distributed
Distributed in 24 states and D.C..
Listed by the agency
Not listed
FDA distribution: “U.S.: AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, and WV. O.U.S.: N/A” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Virginia, West Virginia.
Recall timeline
FDA published this recall 3 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0947-2022 (January 24, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0947-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.